vaccine brands

0.5ML/DOSE/SYRINGE WHICH CONSISTS OF 23 SEROTYPES OF PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES

EACH DOSE (05 ML) IS FORMULATED TO CONTAIN TETANUS TOXOID 5 LF DIPHTHERIA TOXOID 2 LF ACELLULAR PERTUSSIS( PERTUSSIS TOXOID (PT) 25 G AND FILAMENTOUS HAEMAGGLUTININ (FHA) 5 G PERTACTIN (PRN) 3 G FIMBRIAE TYPES 2 AND 3 (FIM) 5 G ) INACTIV

40 IU

LIVE ATTENUATED BCG VACCINE (BACILLUS CLMETTE GUERIN STRAIN) : EACH 0.1 ML CONTAINS BETWEEN 1 X 105 AND 33 X 105 C.F.U.

2-8 X 105 CFU

EACH DOSE OF 2 DROPS (0.1 ML) CONTAINS POLIO VIRUS (SABIN), GROWN ON PRIMARY MONKEY KIDNEY CULTURE:POLIO VIRUS (SABIN)TYPE 1 ? 106 CCID50

EACH DOSE OF 2 DROPS (0.1 ML) CONTAINS POLIO VIRUS (SABIN), GROWN ON PRIMARY MONKEY KIDNEY CULTURE:POLIO VIRUS (SABIN)TYPE 1 ? 106 CCID50

MIN. 2.8 LOG10 EID50 PER DOSE

DIPHTHERIA TOXOID 25 LF (NMT 30 IU), TETANUS TOXOID 5.5 LF ( NMT 60 IU), BORDETELLA PERTUSSIS 16 IOU (NMT 4 IU), HEPATITIS B (RDNA) 12.5 MICROGRAMS, HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED ) 11 MICROGRAMS

DIPHTHERIA, TETANUS, PERTUSSIS (WHOLE CELL), HEPATITIS B (RDNA) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED) - 10 DOSE

EACH DOSE OF 0.5 ML CONTAINS: DIPHTHERIA TOXOID20 LF , 30 LF (30 IU) ,TETANUS TOXOID5 LF 25 LF (60 IU), B. PERTUSSIS WHOLE CELL INACTIVATED4 IU: HEPATITIS B SURFACE ANTIGEN (RDNA)-10MG

ONE DOSE (0.5 ML) CONTAINS: ADENOVIRUS TYPE 26 ENCODING THE SARS-COV-2 SPIKE GLYCOPROTEIN* (AD26.COV2-S), NOT LESS THAN 2.5 × 1010 VIRUS PARTICLES OF AD26.COV2-S OR NOT LESS THAN 8.92 LOG10 INFECTIOUS UNITS (INF.U).

Suspension For Injection

DIPHTHERIA TOXOID 2 LF (>/ 2 IU), TETANUS TOXOID 8.8 LF (>/20 IU), ADSORBED ON ALUMINIUM PHOSPHATE (ALPO4) >/ 1.5MG, THIOMERSAL BP 0.01%W/V

EACH SINGLE 05 ML HUMAN DOSE CONTAINS DIPHTHERIA TOXOID 25 LF (30 IU) TETANUS TOXOID 5 LF ( 40 IU) B PERTUSSIS 16 OU ( 4 IU)

EACH SINGLE 0.5 ML HUMAN DOSE CONTAINS DIPHTHERIA TOXOID 25 LF (30 IU) TETANUS TOXOID 5 LF ( 40 IU) B. PERTUSSIS 16 OU ( 4 IU) HBSAG (RDNA) 10 MCG

EACH DOSE OF 0.5 ML CONTAINS: DIPHTHERIA TOXOID 25 LF ( 30 IU) TETANUS TOXOID 2.5 LF ( 40 IU) B. PERTUSSIS VACCINE

EACH DOSE OF 0.5 ML OF PENTAVALENT VACCINE CONTAINS: COMPONENTS CONCENTRATION DIPHTHERIA TOXOID 20 LF (30 IU) TETANUS TOXOID 7.5 LF (60 IU) INACTIVATED W-B. PERTUSSIS

10 G HBSAG.

2100 L.E.U/1.5ML

1,500 L.E.U/1.5ML

20 MCG HUMAN PAPILLOMA VIRUS TYPE 6 L1 PROTEIN, 40 MCG HUMAN PAPILLOMA VIRUS TYPE 11 L1 PROTEIN, 40 MCG HUMAN PAPILLOMA VIRUS TYPE 16 L1 PROTEIN, 20 MCG HUMAN PAPILLOMA VIRUS TYPE 18 L1 PROTEIN.

EACH 0.5 ML DOSE CONTAINS APPROXIMATELY: 30 MCG HPV TYPE 6 L1 PROTEIN, 40 MCG HPV TYPE 11 L1 PROTEIN, 60 MCG HPV TYPE 16 L1 PROTEIN, 40 MCG HPV TYPE 18 L1 PROTEIN, 20 MCG HPV TYPE 31 L1 PROTEIN, 20 MCG HPV TYPE 33 L1 PROTEIN, 20 MCG HPV TYPE 45 L1 PROTEIN, 20 MCG HPV TYPE 52 L1 PROTEIN, 20 MCG HPV TYPE 58 L1 PROTEIN.

EACH 0.5 ML DOSE CONTAINS APPROXIMATELY : 30 MCG HPV TYPE 6 L1 PROTEIN 40 MCG HPV TYPE 11 L1 PROTEIN, 60MCG HPV TYPE 16 L1 PROTEIN, 40 MCG HPV TYPE 18 L1 PROTEIN, 20 MCG HPV TYPE 31 L1 PROTEIN, 20 MCG HPV TYPE 33 L1 PROTEIN, 20 MCG HPV TYPE 45 L1 PROTEIN, 20 MCG HPV TYPE 52 L1 PROTEIN, 20 MCG HPV TYPE 58 L1 PROTEIN.

DOSE

EACH DOSE OF 0.5 ML CONTAINS PURIFIED CAPSULAR POLYSACCHARIDE (PRP) 10MCG AND TETANUS TOXOID (CARRIER PROTEIN) 19-33MCG

1440 EU/ML

720 EU/0.5 ML

6.5 UNIT / 0.5 ML

500U/DOSE FOR ADULT USE

EACH DOSE OF 1 ML CONTAINS PURIFIED HEPATITIS B SURFACE ANTIGEN 20 MCG

EACH DOSE OF 0.5 ML CONTAINS PURIFIED HEPATITIS B SURFACE ANTIGEN 10 MCG

DIPHTHERIA TOXOID LESS THAN/EQUALS TO 30 IU, TETANUS TOXOID LESS THAN/EQUALS TO 40 IU, BORDETELLA PERTUSSIS (WHOLE CELL)LESS THAN/EQUALS TO4 IU, HEPATITIS B SURFACE ANTIGEN (RDNA)15 MICROGRAM, INACTIVATED POLIO VACCINE (SALK STRAINS GROWN ON VERO CELLS) TYPE -1 (MAHONEY STRAIN)40 DU TYPE -2 (MEF-1 STRAIN) 8 DU TYPE -3(SAUKETT STRAIN)32 DU,HAEMOPHILUS INFLUENZAE TYPE B (PRP) 10 MICROGRAM CONJUGATED TO TETANUS TOXOID (CARRIER PROTEIN)-19 TO 33 MICROGRAM

EACH 0.5 ML DOSE CONTAINS:DIPHTHERIA TOXOID NOT LESS THAN 20IUTETANUS TOXOID NOT LESS THAN 40 IU PERTUSSIS TOXOID 25 MCGFILAMENTOUS HAEMAGGLUTININ 25 MCGPOLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY) 40 D ANTIGEN UNITS TYPE 2 (MEF-1) 8 D ANTIGEN UNIT

10 MCG/0.5 ML

LIVE CANINE PARVOVIRUS (CPV) STRAIN C-780916 10TCID50 LIVECANINE DISTEMPER VIRUS (CDV) LEDERLE STRAIN 10TCID50 LIVE CANINE ADENOVIRUS TYPE 2 (CAV 2) MANHATTAN STRAIN 10DICT50 LIQUID PORTION: INACTIVATED LEPTOSPIA ICTEROHAEMORRHAGIAE & LEPTOSPIR

1 DOSE/BIRD

1 DOSE/BIRD

INACTIVATED RABIES VACCINE

2.5 I.U.

ONE DOSE (0.5ML)

30IU 40IU: 58MCG RESPECTIVELY

30IU 40IU 58MCG 10MCGS RESPECTIVELY

0.5ML/VIAL. EACH SINGLE DOSE IS 0.5ML, CONTAINING 15 MICROGRAMS OF HEMAGGLUTININ OF EACH OF THE INFLUENZA VIRUS STRAINS

INFLUENZA VIRUS (SURFACE ANTIGEN, INACTIVATED NAMELY: - A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215) 15 MICROGRAMS HA , A/DARWIN/9/2021 (H3N2)-LIKE STRAIN (A/DARWIN/6/2021, IVR-227) 15 MICROGRAMS HA , B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26) 15 MICROGRAMS HA , B/PHUKET/3073/2013-LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE) 15 MICROGRAMS HA PER 0,5 ML DOSE

0.15MG OF MYCOPLASMA CAPRICOLUM PER ML, STRAIN F38 BIOTYPE

10POWER 2.5(TCID50) PER DOSE

DOSE

MEASLES VIRUS (CAM-70 STRAIN), PROPAGATED IN CHICKEN EMBRYO FIBROBLAST CELLS 1000 CCID50, RUBELLA VIRUS (WISTAR RA 27/3 STRAIN), PROPAGATED IN MRC 5 CELLS 1000 CCID50

EACH SINGLE HUMAN DOSE WHEN RECONSTITUTED IN A VOLUME OF 0.5 ML CONTAINS NOT LESS THAN 1000 CCID50 OF MEASLES VIRUS.